Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Myasthenia Gravis × Sugars × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4 Prostatic Neoplasms 3 Neoplasms 2 Vomiting 1 Peripheral Nervous System Diseases 1 Periampullary Carcinoma Nos 1 Pediatric Crohn's disease 1 Pain 1 Nausea 1 Myasthenia Gravis 1 Memory Disorders 1 Leiomyoma 1 Hot Flashes 1 Fatigue 1 Cognitive Dysfunction 1 Cancer Pain 1 Anemia 1

Interventions

rozanolixizumab 6 zilucoplan 5 efgartigimod alfa 5 eculizumab 4 telitacicept 3 Tacrolimus 3 Amifampridine 3 ravulizumab 2 Rituximab 2 Prednisone 2 HBM9161 2 satralizumab 1 remibrutinib 1 iptacopan 1 inebilizumab 1 Thymectomy 1 Sugars 1 Steroids 1 Sodium Chloride 1 Pyridostigmine Bromide 1 Prednisolone 1 Mycophenolic Acid 1 Leflunomide 1 Hizentra 1 Cladribine 1 Azathioprine 1 Alkalies 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00995722 2017-06-02

EPITOME'

University of Miami

Phase 3 Terminated

11 enrolled 14 charts

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡